These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 11781357)

  • 1. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus.
    Finck BN; Lehman JJ; Leone TC; Welch MJ; Bennett MJ; Kovacs A; Han X; Gross RW; Kozak R; Lopaschuk GD; Kelly DP
    J Clin Invest; 2002 Jan; 109(1):121-30. PubMed ID: 11781357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content.
    Finck BN; Han X; Courtois M; Aimond F; Nerbonne JM; Kovacs A; Gross RW; Kelly DP
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1226-31. PubMed ID: 12552126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD36 deficiency rescues lipotoxic cardiomyopathy.
    Yang J; Sambandam N; Han X; Gross RW; Courtois M; Kovacs A; Febbraio M; Finck BN; Kelly DP
    Circ Res; 2007 Apr; 100(8):1208-17. PubMed ID: 17363697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragalus polysaccharides repress myocardial lipotoxicity in a PPARalpha-dependent manner in vitro and in vivo in mice.
    Chen W; Lai Y; Wang L; Xia Y; Chen W; Zhao X; Yu M; Li Y; Zhang Y; Ye H
    J Diabetes Complications; 2015 Mar; 29(2):164-75. PubMed ID: 25499591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart.
    Burkart EM; Sambandam N; Han X; Gross RW; Courtois M; Gierasch CM; Shoghi K; Welch MJ; Kelly DP
    J Clin Invest; 2007 Dec; 117(12):3930-9. PubMed ID: 18037994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The critical role of Astragalus polysaccharides for the improvement of PPARα [ correction of PPRAα]-mediated lipotoxicity in diabetic cardiomyopathy.
    Chen W; Xia Y; Zhao X; Wang H; Chen W; Yu M; Li Y; Ye H; Zhang Y
    PLoS One; 2012; 7(10):e45541. PubMed ID: 23049681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPAR signaling in the control of cardiac energy metabolism.
    Barger PM; Kelly DP
    Trends Cardiovasc Med; 2000 Aug; 10(6):238-45. PubMed ID: 11282301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.
    Duncan JG; Bharadwaj KG; Fong JL; Mitra R; Sambandam N; Courtois MR; Lavine KJ; Goldberg IJ; Kelly DP
    Circulation; 2010 Jan; 121(3):426-35. PubMed ID: 20065164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid metabolism assessed by 125I-iodophenyl 9-methylpentadecanoic acid (9MPA) and expression of fatty acid utilization enzymes in volume-overloaded hearts.
    Miyamoto T; Takeishi Y; Tazawa S; Inoue M; Aoyama T; Takahashi H; Arimoto T; Shishido T; Tomoike H; Kubota I
    Eur J Clin Invest; 2004 Mar; 34(3):176-81. PubMed ID: 15025675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy with Astragalus polysaccharides rescues lipotoxic cardiomyopathy in MHC-PPARα mice.
    Chen W; Chen W; Xia Y; Zhao X; Wang H; Yu M; Li Y; Ye H; Zhang Y
    Mol Biol Rep; 2013 Mar; 40(3):2449-59. PubMed ID: 23196711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart.
    Finck BN; Kelly DP
    J Mol Cell Cardiol; 2002 Oct; 34(10):1249-57. PubMed ID: 12425323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
    Aasum E; Cooper M; Severson DL; Larsen TS
    Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice.
    Djouadi F; Weinheimer CJ; Saffitz JE; Pitchford C; Bastin J; Gonzalez FJ; Kelly DP
    J Clin Invest; 1998 Sep; 102(6):1083-91. PubMed ID: 9739042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPAR ligands improve impaired metabolic pathways in fetal hearts of diabetic rats.
    Kurtz M; Capobianco E; Martinez N; Roberti SL; Arany E; Jawerbaum A
    J Mol Endocrinol; 2014 Oct; 53(2):237-46. PubMed ID: 25122159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor alpha is downregulated in the failing human heart.
    Karbowska J; Kochan Z; Smoleński RT
    Cell Mol Biol Lett; 2003; 8(1):49-53. PubMed ID: 12655356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
    Pellieux C; Aasum E; Larsen TS; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
    J Mol Cell Cardiol; 2006 Sep; 41(3):459-66. PubMed ID: 16859699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response.
    Feingold K; Kim MS; Shigenaga J; Moser A; Grunfeld C
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E201-7. PubMed ID: 14701665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic cardiomyopathy.
    Feuvray D
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):261-5. PubMed ID: 15106750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-alpha transgenic mice.
    Hopkins TA; Sugden MC; Holness MJ; Kozak R; Dyck JR; Lopaschuk GD
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H270-6. PubMed ID: 12663261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet.
    He J; Quintana MT; Sullivan J; L Parry T; J Grevengoed T; Schisler JC; Hill JA; Yates CC; Mapanga RF; Essop MF; Stansfield WE; Bain JR; Newgard CB; Muehlbauer MJ; Han Y; Clarke BA; Willis MS
    Cardiovasc Diabetol; 2015 Aug; 14():97. PubMed ID: 26242235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.